Roche says FDA approves HPV self-test in US

Logo of Swiss drugmaker Roche is seen in Basel

BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit.

Screening for HPV can help identify women who are at risk of developing cervical cancer at an earlier stage.

(Reporting by Rachel More, writing by Andrey Sychev)